ADP-Ribosylation Factor-Like 4A (ARL4A) (Middle Region) Peptid
ARL4A
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN5672361
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für ADP-Ribosylation Factor-Like 4A (ARL4A) (Middle Region) Peptid (ABIN5672361)
Target
ARL4A
(ADP-Ribosylation Factor-Like 4A (ARL4A))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequenz
- HFWDVGGQEK LRPLWKSYTR CTDGIVFVVD SVDVERMEEA KTELHKITRI
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- ARL4A Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
ADP-Ribosylation Factor-Like 4A (ARL4A) peptide
ARL4A Reaktivität: Human, Maus, Schwein, Ratte Wirt: Synthetic BP, Imm
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ARL4A (ADP-Ribosylation Factor-Like 4A (ARL4A))
-
Hintergrund
-
ADP-ribosylation factor-like 4A is a member of the ADP-ribosylation factor family of GTP-binding proteins. ARL4A is similar to ARL4C and ARL4D and each has a nuclear localization signal and an unusually high guaninine nucleotide exchange rate. ARL4A is located in both the nuclear and extranuclear cell compartments. Multiple transcript variants encoding the same protein have been found for this gene.
Alias Symbols: ARL4
Protein Size: 200 -
Gen-ID
- 10124
-
NCBI Accession
- NM_001037164, NP_001032241
-
UniProt
- P40617
Target
-
Sie sind hier:
